PHOFAY Matte Sunscreen Liquid Foundation SPF 30 5
- Manufacturer
- Hangzhou Jingshen Trading Co., Ltd.
- Effective date
- 2025-09-06
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-06-01 01:12:43
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Ensulizole 2%,Homosalate 5%,Octinoxate 4.995%,Titanium Dioxide 10.725%
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
if product is swallowed,get medical help or contact a poison control center right away.
WARNINGS SECTION
For external use only
Do not use on damaged or broken skin
When using this product keep out of eyes.
rinse with water to remove.
Stop Use And Ask A Doctor lf
rash or irritation develops and lasts
keep out of reach of children.
if product is swallowed,get medical help or contact a poison control center right away.
DOSAGE & ADMINISTRATION SECTION
For sunscreen use:
apply liberally 15 minutes before sun exposure
reapply at least every two hours
use a water resistant sunscreen if swimming or sweating
wear long-sleeved shirts, pants, hats and sunglasses
children under 6 months :Ask a doctor
OTHER SAFETY INFORMATION
protect the product in this container from excessive
heat and direct sun
INACTIVE INGREDIENT SECTION
Water, Glycerin, Silica, C12-15 Alkyl Benzoate, Phenyl Trimethicone, Butylene Glycol, Cyclopentasiloxane, Polyglyceryl-3 Diisostearate, Sorbitan Isostearate, Tridecyl Trimellitate, Diisostearyl Malate, Polyglyceryl-2 Dipolyhydroxystearate,Phenoxyethanol, Triethoxycaprylylsilane, Disteardimonium Hectorite, Polyhydroxystearic Acid, Magnesium Sulfate, Sodium Chloride, Alumina,Sodium Hydroxide, Fragrance, Ethylhexylglycerin, BHT,Iron Oxides(CI 77492,CI 77491,CI 77499)
OTC - PURPOSE SECTION
Suncreen
INDICATIONS & USAGE SECTION
helps prevent sunburn
provides high protection against sunburn and tanning
lf used as directed with other sun protection measures.
decreases the risk of skin cancer and early skin aging caused by the sun
OTC - QUESTIONS SECTION
Call 1-818-579-72880 or 1-818-688-3208
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 87080-105-01 | PHOFAY Matte Sunscreen Liquid Foundation SPF 30 5 | 1 g in 1 BOTTLE | LOTION | 1 | 2 | |
| 87080-105-01 | PHOFAY Matte Sunscreen Liquid Foundation SPF 30 5 | 1 in 1 BOX | LOTION | 1 | 2 |
Products#
Every source-derived product name is available through these pages.
- PHOFAY Matte Sunscreen Liquid Foundation SPF 30 5
- Ensulizole ,Homosalate ,Octinoxate,Titanium Dioxide
- SODIUM HYDROXIDE
- FRAGRANCE LEMON ORC2001060
- BUTYLENE GLYCOL
- BHT
- POLYHYDROXYSTEARIC ACID (2300 MW)
- MAGNESIUM SULFATE
- SILICON DIOXIDE
- TRIDECYL TRIMELLITATE
- ETHYLHEXYLGLYCERIN
- SORBITAN ISOSTEARATE
- TITANIUM DIOXIDE
- WATER
- CYCLOPENTASILOXANE
- ENSULIZOLE
- HOMOSALATE
- CI 77492
- C12-15 ALKYL BENZOATE
- ALUMINA
- OCTINOXATE
- PHENYL TRIMETHICONE
- POLYGLYCERYL-3 DIISOSTEARATE
- DISTEARDIMONIUM HECTORITE
- GLYCERIN
- DIISOSTEARYL MALATE
- POLYGLYCERYL-2 DIPOLYHYDROXYSTEARATE
- SODIUM CHLORIDE
- CI 77499
- PHENOXYETHANOL
- CI 77491
- TRIETHOXYCAPRYLYLSILANE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 87080-105 | 87080-105-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PHOFAY Matte Sunscreen Liquid Foundation SPF 30 5 | ENSULIZOLE ,HOMOSALATE ,OCTINOXATE,TITANIUM DIOXIDE | Hangzhou Jingshen Trading Co., Ltd. | 3dbb07e2-971c-284d-e063-6294a90a437f | 2025-09-06 | Warnings | 87080-105-01 87080-105 87080010501 3e1e85df-e30d-8f38-e063-6394a90a86bc 3dbb07e2-971c-284d-e063-6294a90a437f |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
